Bayer CropScience Ltd. Share Price

Overview

Bayer CropScience Ltd. share price is currently ₹3,313.29, down by - ₹77.56 (2.29%) from its previous closing price of ₹3,390.85. The share price has declined -11.29% over the past month and declined -33.67% over the past year. The stock's 52-week low and high are ₹3,240.20 and ₹5,011.30, respectively. Bayer CropScience Ltd. has a market capitalisation of ₹ 16,350.00 Cr. The share price was last updated on 23 Oct 2026, 03:57 PM IST.

Bayer CropScience Ltd.
Bayer CropScience Ltd.
BAYERCROP
 ₹0.00
- ₹77.56
2.29%
Chemicals
 ₹0.00(%)1D

Updated: 23 Oct 2026, 03:57:44 pm IST

Market Data

Open Price

 ₹3,381.29

Prev. Close

 ₹3,390.85
 ₹3,240.20

Day Low

 ₹3,381.29

Day High

 ₹3,240.20

52 Week Low

 ₹5,011.30

52 Week High

ChemicalsPesticides & Agrochemicals
CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

20.32

Sector PE

28.52

PB Ratio

5.02

Sector PB

4.06

EPS

163.05

Dividend Yield

3.22

Today's Volume

44.976 K

5 Day Avg. Volume

22.756 K

PEG Ratio

0.95

Market Cap.

₹ 16,350.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 600% at ₹60/Share
05-Aug-202605-Aug-2026
DividendsInterim Dividend of 900% at ₹90/Share
14-Nov-202514-Nov-2025
DividendsFinal Dividend of 350% at ₹35/Share
07-Aug-202507-Aug-2025
DividendsInterim Dividend of 900% at ₹90/Share
28-Nov-202428-Nov-2024

Mutual Fund Ownership

Mutual Fund Holder
Aug 26
Shares held
Sep 26
Shares held
Quant Small Cap Fund - Growth10.37 Lac
10.37 Lac
no change
DSP Small Cap Fund - Regular Plan - Growth5.78 Lac
5.78 Lac
no change
Nippon India Small Cap Fund - Growth5.66 Lac
5.66 Lac
no change
Aditya Birla Sun Life Large Cap Fund - Regular Plan - Growth3.29 Lac
3.29 Lac
no change
DSP Multi Asset Allocation Fund - Regular Plan - Growth1.96 Lac
1.96 Lac
no change

About Bayer CropScience Ltd. 👋

Bayer CropScience Limited is an India-based company, which is engaged in the manufacturing, sale and distribution of insecticides, fungicides, herbicides and various other agrochemical products and corn seeds. The Company operates through the Agri Care segment. The Company's operations include three business areas: Crop Protection, Seeds & Traits and Digital Farming. Its Crop Protection portfolio comprises a wide range of chemical and biological pest management solutions. Its Seeds & Traits develops seeds and traits that provide farmers with new solutions. Its Digital Farming consists of modern farming methods that use technology to improve crop yield and efficiency while reducing waste and environmental impact. The Company offers various brands, such as Alion Plus, Movento Energy, Solomon, Lesenta, Nativo, Permethrin, Sectin, Topstar, and others.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
CA Sumit Mangla

CA Sumit Mangla

21 Jul • 7:21 PM · SEBI-Registered Analyst

Rallis India Flags Weak Outlook: Cotton Seed & Crop Protection Volumes Unlikely to Grow Amid Weak Monsoons & Illegal Trade

InGovern or analyst updates aside,

RALLIS
management during its recent concall confirmed subdued growth expectations for key segments. Commentary that cotton seed and crop protection product volumes are unlikely to see meaningful growth this fiscal year. This is primarily attributed to deficient and uneven monsoons impacting sowing patterns, coupled with rampant illegal trade in unapproved HTBt (herbicide-tolerant Bt) cotton seeds, which disrupts legitimate seed demand and farmer sentiments, especially in key states like Maharashtra, Gujarat, and Telangana. The cautious outlook underscores Rallis' transparent governance as a Tata enterprise, potentially building long-term investor trust. Strong Q1FY26 performance (revenue up ~20-22% YoY to ~₹957 Cr, PAT nearly doubled to ₹95 Cr, EBITDA margins expanding) shows resilience through diversified seeds (paddy, maize, mustard), exports, and new product launches in crop care. Weak volume growth in cotton and crop protection—core to domestic business—could pressure overall revenue and profitability, exacerbating challenges from weather variability and illegal competition. This may lead to higher inventory, margin compression in affected segments, delayed farmer spending, and stock volatility, especially if monsoons remain weak, affecting the broader agri-input cycle and Rallis' seeds business contribution. Near-term, Rallis India shares may face selling pressure on growth concerns. It could negatively ripple to other agri-input players like
COROMANDEL
, PI Industries,
UPL
,
BAYERCROP
.

See More
Dhwani Patel

Dhwani Patel

7 Jul • 12:26 PM · SEBI-Registered Analyst

BAYERCROP

BAYERCROP
has reached a key support zone that has held multiple times during 2023 and 2024. This area has previously attracted strong buying interest, making it an important level to watch. A sustained hold above this support could trigger a meaningful rebound, while a breakdown would weaken the current technical structure.

See More
Naveen Kumar

Naveen Kumar

26 May • 10:22 AM · SEBI-Registered Analyst

BHARATRAS
good result is expected

harat Rasayan is a specialty agrochemical company (technical-grade pesticides). Q3 FY26 revenue Rs 287 Cr, up 9.2% YoY, with net profit Rs 40 Cr (up 44% QoQ vs Q2's Rs 28 Cr). EBITDA margin improved to 17.25% in Q3 vs 15% in Q2, signalling margin recovery trend. 9M FY26 revenue Rs 934 Cr and profit Rs 104 Cr, showing overall improvement. Key driver: global agrochemical de-stocking cycle (2023-25) now ending with restocking beginning. Peers: PI Industries reported strong Q4 with export growth; Dhanuka Agritech reported better margins; Rallis India showed recovery; Bayer CropScience (parent: Bayer AG) improved Q1 2026 globally. India rabi crop season (Jan-Mar) is key demand period for Bharat Rasayan. Board meeting May 26, 2026 to approve FY26 audited results. Promoter confidence visible (stable holding). With 9M FY26 PAT at Rs 104 Cr, Q4 required only Rs 40-50 Cr to hit FY26 targets. Margins improving YoY and industry cycle turning. Expect Q4 FY26 revenue Rs 300-320 Cr, PAT Rs 40-50 Cr, EBITDA margin 16-18%.

See More
Dhwani Patel

Dhwani Patel

16 Apr • 5:41 PM · SEBI-Registered Analyst

BAYERCROP
Upward shift

Price is trading within a rising channel, respecting both support and resistance boundaries. Recent bounce from lower trendline suggests buyers stepping in at key support. A move toward upper channel or breakout above it can signal continuation of the uptrend in

BAYERCROP

See More
SASI KUMAR SEBI RA

SASI KUMAR SEBI RA

11 Feb • 9:42 PM · SEBI-Registered Analyst

Bayer Crop Science Q3 FY26 – Margins Improve Sharply

Bayer Crop Science reported a steady December 2025 quarter. While revenue growth was modest, profitability improved significantly on a year-on-year basis, indicating better margins and operating efficiency. • Sales: ↑ 5% YoY to ₹1,106 crore (vs ₹1,057 crore in Dec 2024) • EBIDT: ↑ 480% YoY to ₹117 crore (vs ₹20.2 crore) • Net Profit: ↑ 180% YoY to ₹95.7 crore (vs ₹34.2 crore) • EPS: ↑ 180% YoY to ₹21.29 (vs ₹7.61) At a price of ₹4,762, market cap ₹21,455 crore, and PE 32, Bayer Crop Science is showing strong improvement in profitability despite limited top-line growth. Overall, the quarter reflects margin recovery and operational strength, though consistent revenue growth will be important for sustained long-term momentum.

See More
Dhwani Patel

Dhwani Patel

10 Feb • 2:40 PM · SEBI-Registered Analyst

BAYERCROP
- Descending triangle upward breakout

A descending triangle upward breakout is seen in

BAYERCROP
on daily chart with upside bias towards 5200 - 5300

News & Events

Frequently Asked Questions

What is the share price of Bayer CropScience Ltd.?

What is the market cap of Bayer CropScience Ltd.?

Should I buy Bayer CropScience Ltd. stock now?

What is the 52 week high and low of Bayer CropScience Ltd.?

Is the Bayer CropScience Ltd. stock good to buy?

Is Bayer CropScience Ltd. a good buy for the long term?

Is Bayer CropScience Ltd. overvalued or undervalued?

What is the PE and PB ratio of Bayer CropScience Ltd.?

Start Now